This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Genentech, Inc.. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2025
Title: Samir Bouayad-Gervais: Innovator in Therapeutic Compounds
Introduction
Samir Bouayad-Gervais is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in developing therapeutic compounds aimed at treating serious diseases.
Latest Patents
Samir holds 2 patents that focus on innovative therapeutic solutions. His latest patents include "Therapeutic compounds and methods of use," which relates to compounds and methods for treating diseases mediated by TEAD, such as cancer. Another significant patent is for "Pyrazolo compounds and methods of use thereof," which also addresses treatments for conditions mediated by TEAD, including cancer.
Career Highlights
Samir is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His work at Genentech has allowed him to explore and develop groundbreaking therapeutic solutions that have the potential to impact patient care significantly.
Collaborations
Throughout his career, Samir has collaborated with talented professionals, including Jason R Zbieg and Paul Powell Beroza. These collaborations have fostered an environment of innovation and creativity, contributing to the advancement of therapeutic research.
Conclusion
Samir Bouayad-Gervais is a dedicated inventor whose work in therapeutic compounds is paving the way for new treatments for serious diseases. His contributions to the field are invaluable and highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile